|
?:authorAffiliation
|
-
[\'Health Risks Program, Burnet Institute, Melbourne, Australia. amanda.roxburgh@burnet.edu.au.\', \'Discipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of Sydney, Sydney, Australia. amanda.roxburgh@burnet.edu.au.\', \'National Drug and Alcohol Research Centre, UNSW, Sydney, Australia. amanda.roxburgh@burnet.edu.au.\', \'Monash Addiction Research Centre, Monash University, Melbourne, Australia. amanda.roxburgh@burnet.edu.au.\', \'Discipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health, University of Sydney, Sydney, Australia.\', \'National Drug and Alcohol Research Centre, UNSW, Sydney, Australia.\', \'Uniting Medically Supervised Injecting Centre, Sydney, Australia.\', \'North Richmond Community Health Medically Supervised Injecting Room, Melbourne, Australia.\', \'Health Risks Program, Burnet Institute, Melbourne, Australia.\', \'Monash Addiction Research Centre, Monash University, Melbourne, Australia.\', \'Addiction Medicine, Royal Melbourne Hospital, Melbourne, Australia.\', \'Department of Pharmacology, University of Adelaide, Adelaide, Australia.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}